All In Biotech

Investigational drug · Phase 3

DFL24498

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Dry Eye Disease (DED), Atopic Keratoconjunctivitis.

Phase 3

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

2

Any phase or sponsor naming "DFL24498"

First trial start

2025

Dec 1, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "DFL24498", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Dry Eye Disease (DED)
  • Atopic Keratoconjunctivitis

Approved drugs for the same conditions: Dry eye disease · Ophthalmology

Largest trials

Live from ClinicalTrials.gov: studies naming "DFL24498" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Dry Eye Disease (DED)

  • licaminlimabPhase 31 trial

    Oculis · Dry Eye Disease (DED)

  • 0.25% RCI001RCI001Phase 22 trials

    ORA, Inc. · Dry Eye Disease (DED), Dry Eye

  • TTAX03Phase 22 trials

    BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis

  • BRM421Phase 21 trial

    BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.